PARP Inhibitors for the Treatment of Ovarian Cancer - Gottfried Konecny, MD | UCLAMDChat

UCLA oncologist Gottfried Konecny, MD, gives an overview of the PARP inhibitors olaparib, niraparib, and rucaparib, which have been approved for the treatment of ovarian cancers and how to proactively plan for and manage treatment-related toxicities. #UCLAMDChat

[alaskansourdoughwormsgarde]

I am on Lynparzza and this helped me understand a lot more than I did.

[impamiizgraa]

Absolutely fantastic. Best PARPi video I've ever seen - this helped me SO MUCH. THANK YOU!

[keezer]

This was the clear explanation I was looking for. More doctors like you should make videos like this. I appreciate the time you took to explain this new therapy!

[sunilarora]

Thankyou... found this gem after almost three hours of hearing jargons on other channels:-)

[kouklakee]

Excellent! You have answered so many of my questions! Thank You 🙏🏼

[widescreen]

I love science. Great presentation, thanks Gottfried

[juktachatterjee]

Plz sir reply me plzzzz... Can I take Rucaparib with in 6 months of last chemo Plz sir help me😭

[dautaykem]

Character In the video It's great, I like it a lot $$

[kimzastrow]

Is that from great America and the spit in the eye